INNOVENT BIOLOGICS INC earnings per share and revenue

1801 earnings per share for the last semiannual are -0.63 HKD whereas the estimation was -0.55 HKD which accounts for -14.00% surprise. Company revenue for the same period amounts to 3.86 B HKD despite the estimated figure of 3.76 B HKD. Estimated earnings per share for the next semiannual are -0.36 HKD, and revenue is expected to reach 3.89 B HKD. Also watch annual changes over time to get a bigger picture of 1801 earnings per share and revenue dynamics.